Skip to Content

WATSON 3219 (Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg)

Pill imprint WATSON 3219 has been identified as Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg.

Aspirin/butalbital/caffeine is used in the treatment of migraine; pain; headache and belongs to the drug class analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine 325 mg / 50 mg / 40 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine 325 mg / 50 mg / 40 mg WATSON 3219
Aspirin, butalbital and caffeine
Imprint:
WATSON 3219
Strength:
325 mg / 50 mg / 40 mg
Color:
Green & Yellow
Size:
29.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Analgesic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
3 - Moderate abuse potential
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3219
Inactive Ingredients:
microcrystalline cellulose
corn starch
magnesium silicate
D&C Yellow No. 10
FD&C Green No. 3
gelatin
ferric oxide red
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0934 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide